Precision Gut-Brain Axis Interventions in Ischemic Stroke: Molecular Mechanisms, Microbiota Dysbiosis, and Sex-Dimorphic Therapeutic Targets

Abstract

Ischemic stroke represents a leading cause of global mortality and long-term disability. Emerging biomedical paradigms highlight the bidirectional gut-brain-immune axis as a fundamental determinant of cerebrovascular pathology. Pre-existing gut dysbiosis predisposes individuals to aggravated ischemic injury, while acute cerebral ischemia triggers systemic neuroendocrine and autonomic responses that exacerbate intestinal dysbiosis, gut epithelial hyperpermeability, and bacterial translocation. Mechanistically, altered microbial metabolite profiles—characterized by depleted short-chain fatty acids (SCFAs) and elevated trimethylamine N-oxide (TMAO)—regulate neuroinflammation via Toll-like receptor 4 (TLR4), NLRP3 inflammasome activation, and microglial polarization. Crucially, the gut microbiome exhibits marked sex dimorphism driven by chromosomal factors and gonadal steroids. Estrogen signaling via the estrobolome modulates gut barrier integrity, microbial diversity, and neuroprotective SCFA signaling, yielding sexually divergent neuroinflammatory outcomes post-ischemia. This review delineates the cellular and molecular cascades linking gut dysbiosis to ischemic stroke, emphasizes the biological variable of sex in gut-brain interactions, and outlines precision microbiome-targeted therapeutic interventions to optimize clinical outcomes in precision neurovascular medicine.

Introduction & Cellular Mechanisms

Cerebral ischemia initiates a rapid inflammatory cascade that extends beyond the central nervous system (CNS) to involve systemic organ systems, notably the gastrointestinal tract. The bidirectional gut-brain-immune axis plays a pathophysiological role in modulating the extent of ischemic penumbra salvage, neuroinflammation, and post-stroke complications.

```
[Pre-Stroke Dysbiosis / Stroke Onset]
│
▼
[Autonomic / Neuroendocrine Dysfunction] ──► [Gut-Vascular Barrier Breakdown]
│ │
▼ ▼
[Microbial Dysbiosis (↓ SCFAs, ↑ TMAO)] ──► [Systemic Translocation & TLR4/NLRP3 Activation]
│
▼
[Pro-inflammatory Microglial Activation (M1)]
│
▼
[Exacerbated Ischemic Brain Injury]
```

Pre-Stroke Dysbiosis and Ischemic Vulnerability

Pre-existing alterations in the intestinal microbiota—characterized by a reduced *Firmicutes*-to-*Bacteroidetes* ratio, loss of obligate anaerobic butyrate producers (e.g., *Faecalibacterium prausnitzii*), and expansion of pathobionts—prime the systemic immune compartment for exaggerated neuroinflammatory responses. Commensal-derived short-chain fatty acids (SCFAs; acetate, propionate, butyrate) act as crucial endogenous agonists for free fatty acid receptors 2 and 3 (FFAR2/3; GPR43/41) and inhibit histone deacetylases (HDACs). Depletion of SCFAs impairs regulatory T cell ($T_{reg}$) differentiation and enhances the systemic expansion of pro-inflammatory $T_H17$ and $T_H1$ cell populations prior to ischemic onset.

Acute-Phase Pathophysiology: The Ischemic Cascade and Gut Barrier Dysfunction

Following middle cerebral artery occlusion (MCAO), acute cerebral ischemia triggers massive activation of the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system (SNS). Excessive release of norepinephrine and glucocorticoids drives gut hypoperfusion, motor dysmotility, and compromised intestinal epithelial integrity.

1. Tight Junction Disruption: Downregulation of Claudin-5, Occludin, and Zonula Occludens-1 (ZO-1) compromises the gut-vascular barrier (GVB), permitting the systemic translocation of lipopolysaccharide (LPS) and bacterial pathogen-associated molecular patterns (PAMPs).
2. Systemic Inflammatory Cascades: Translocated LPS binds to CD14/TLR4 receptor complexes on circulating monocytes and perivascular macrophages, activating Nuclear Factor Kappa B (NF-$\kappa$B) and inducing systemic surges of pro-inflammatory cytokines, including TNF-$\alpha$, IL-1$\beta$, and IL-6.
3. Organelle Dysfunction and ROS Production: Systemic oxidative stress damages mitochondrial complexes I and III within intestinal enterocytes and microvascular endothelial cells, accelerating cytochrome c release, PARP-1 overactivation, and apoptotic cell death.
4. Microglial Polarization and Neuroinflammation: Systemic inflammation and circulating microbial metabolites breach the compromised blood-brain barrier (BBB). LPS-mediated TLR4 activation drives microglial polarization toward the pro-inflammatory M1 phenotype. This stimulates assembly of the NLRP3 inflammasome complex (comprising NLRP3, ASC, and caspase-1), driving cleavage of pro-IL-1$\beta$ and pro-IL-18 into their active, highly neurotoxic forms, thereby enlarging the ischemic core.

Conversely, microbial conversion of dietary phosphatidylcholine to trimethylamine (TMA) by gut bacterial TMA lyases, followed by hepatic oxidation via flavin-containing monooxygenase 3 (FMO3), yields trimethylamine N-oxide (TMAO). Elevated TMAO directly enhances platelet hyperreactivity via calcium signaling modulation, accelerates atherosclerosis, and amplifies cerebral ischemia-reperfusion injury through reactive oxygen species (ROS) accumulation and endothelial cell pyroptosis.

Sex-Dimorphic Regulation & Translational Implications

Biological sex exerts a profound influence on both gut microbiome architecture and the neuroinflammatory cascade following ischemic stroke. Sex-and-Gender-Based Analysis (SGBA) reveals that gonadal hormones, sex chromosome complement (XX vs. XY), and sex-specific microglial phenotypes generate differential susceptibility to dysbiosis-induced neurovascular damage.

1. Hormonal Modulation of the Gut-Brain Axis and Estrobolome Dynamics

The "estrobolome"—the aggregate of enteric bacterial genes capable of metabolizing estrogens—plays a pivotal role in sex-dimorphic neuroprotection. Bacterial $\beta$-glucuronidases deconjugate bound hepatic estrogens into active 17$\beta$-estradiol ($E_2$), enabling its reabsorption via enterohepatic circulation.

Female Neuroprotection: Endogenous $E_2$ signals through Estrogen Receptor Alpha ($ER\alpha$) and Beta ($ER\beta$) on intestinal enterocytes to upregulate tight junction protein expression, reinforcing GVB integrity and dampening baseline systemic inflammation. $E_2$ acts as a potent negative regulator of the NLRP3 inflammasome and downregulates microglial TLR4 expression, limiting post-ischemic brain infarction in premenopausal females.

Age and Ovarian Senescence: Following menopause or ovariectomy, declining $E_2$ levels disrupt estrobolome equilibrium, leading to marked loss of microbial diversity, reduction in SCFA-producing taxa, and elevated baseline intestinal permeability, which markedly increases stroke risk and neuroinflammatory severity in aged females.

2. Sex-Specific Neuroinflammatory Cascade and Microbial Metabolite Signaling

Microglial transcriptomic profiles are inherently sex-dimorphic. Male microglia exhibit a pre-primed pro-inflammatory state characterized by higher baseline expression of $MHC-II$, $TLR4$, and purinergic receptors ($P2X7R$). Upon ischemic insult, male brains demonstrate accelerated recruitment of gut-derived inflammatory monocytes and $T_H17$ cells, resulting in larger infarct volumes relative to age-matched, pre-menopausal females.

| Biological Axis / Target | Male Phenotype | Female Phenotype (Premenopausal) | Translational Impact |
| :--- | :--- | :--- | :--- |
| Gut Microbiome Composition | Higher relative *Bacteroides* abundance; lower microbial diversity | Elevated *Lactobacillus* and *Bifidobacterium*; higher $\alpha$-diversity | Differential basal immune priming and metabolic output |
| SCFA Production & Sensing | Lower baseline SCFA-mediated $T_{reg}$ induction | Enhanced SCFA-driven anti-inflammatory signaling | Females demonstrate greater baseline resistance to gut-derived neuroinflammation |
| TMAO / FMO3 Pathway | Elevated systemic TMAO sensitivity; higher platelet reactivity | Reduced TMAO-induced endothelial toxicity via $E_2$ protection | Sex-tailored cardiovascular risk stratification and TMAO inhibition |
| Microglial Activation Profile | Predominant M1 polarization; rapid NLRP3 inflammasome assembly | M2 skewing; suppressed IL-1$\beta$ release via $ER\alpha$ signaling | Divergent neuroprotective window for targeted anti-inflammatory agents |

3. Precision Biomarkers and Therapeutics Tailored to Sex-Specific Dysbiosis

Translational applications must account for sex as a biological variable (SABV). Diagnostic strategies utilizing gut microbiota profiling, serum SCFA-to-TMAO ratios, and circulating intestinal fatty acid-binding protein (I-FABP) levels must establish sex-stratified reference intervals.

Therapeutically, male patients benefit preferentially from aggressive SCFA supplementation (e.g., sodium butyrate enemas or oral postbiotics) and targeted TLR4 antagonists to offset their intrinsic pro-inflammatory microglial priming. Conversely, therapeutic paradigms for postmenopausal female patients mandate dual interventions: restoration of estrobolome-mediated estrogen recycling via specific $\beta$-glucuronidase-producing probiotic strains (e.g., specific *Lactobacillus* species) alongside targeted receptor modulation to reconstitute intestinal barrier defense.

Conclusions & Clinical Outlook

The gut-brain axis represents a highly actionable therapeutic target in ischemic stroke. Moving beyond descriptive associations, the field must now decipher precise molecular circuits connecting specific microbial metabolites to immune cell fate and cerebrovascular repair.

Future clinical trajectories rely on precision neuro-gastroenterology strategies:

Targeted Postbiotics and Engineered Microbial Therapeutics: Administration of synthetic SCFA analogs or engineered bacterial strains capable of localized anti-inflammatory metabolite delivery within the hyper-acute window ($<6$ hours post-stroke).

Fecal Microbiota Transplantation (FMT): Utilizing sex-matched, young, healthy donors to restore intestinal homeostasis, attenuate post-stroke dysbiosis, and mitigate stroke-induced systemic inflammatory response syndrome (SIRS).

Integration of Sex-and-Gender-Based Analysis (SGBA): Stratifying clinical trials by sex, age, and hormonal status to ensure microbiome interventions—such as TMA lyase inhibitors or microglial modulators—are tailored to the distinct physiological landscapes of male and female patients.

By integrating multi-omics technologies with sex-specific translational models, precision medicine can harness the gut-brain axis to prevent ischemic events, minimize acute neuro-vascular damage, and enhance long-term functional recovery.

Key Insights

Bidirectional Pathological Cascade: Ischemic stroke induces acute autonomic and neuroendocrine stress that disrupts gut barrier integrity and drives microbial dysbiosis, which in turn feeds back to exacerbate neuroinflammation via translocated PAMPs, NLRP3 activation, and pathogenic microbial metabolites (↑ TMAO, ↓ SCFAs).

Sex-Dimorphic Estrobolome Dynamics: Endogenous $17\beta$-estradiol and the gut estrobolome exert neuroprotective effects in premenopausal females by maintaining gut vascular barrier integrity and suppressing pro-inflammatory microglial M1 polarization, a protection lost following post-menopausal ovarian senescence.

Precision Biomarker & Postbiotic Strategies: Clinical translation requires sex-stratified diagnostic profiling (SCFA/TMAO ratios) and tailored therapeutic paradigms, combining targeted postbiotics, metabolic enzyme inhibitors, and sex-matched microbial restorations to optimize neurovascular outcomes.

References

1. Benakis, C., Brea, D., Caballero, S., Faraco, G., Moore, J., Murphy, M., ... & Iadecola, C. (2016). Commensal microbiota affects ischemic stroke outcome by regulating intestinal $\gamma\delta$ T cells. *Nature Medicine*, 22(5), 516-523. https://doi.org/10.1038/nm.4068
2. Sadler, R., Cramer, J. V., Heindl, S., Kostidis, S., Betz, D., Zuurbier, K. R., ... & Liesz, A. (2020). Short-chain fatty acids improve post-stroke recovery via immunological mechanisms. *Journal of Neuroscience*, 40(5), 1162-1173. https://doi.org/10.1523/JNEUROSCI.1359-19.2019
3. Spychala, M. S., Venna, V. R., Jandzinski, M., Doran, S. J., Durgan, D. J., Bryan, R. M., ... & McCullough, L. D. (2018). Age-related changes in the gut microbiota influence systemic inflammation and stroke recovery. *Annals of Neurology*, 84(1), 23-36. https://doi.org/10.1002/ana.25250 (PMID: 29733457)